Results 1 to 10 of about 582 (66)
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
Frontiers in Endocrinology, 2017 IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Vibhor Wadhwa, Gitanjali Bajaj
exaly +3 more sources
Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023 Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja +6 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi +16 more
doaj +1 more source
Endokrynologia Polska, 2021 On March 11, 2020, the World Health Organisation (WHO) observed the scale of epidemic risk and declared the state of the COVID-19 pandemic. Most countries, including Poland, implemented national and local emergency management plans to deal with the ...
Beata Matyjaszek-Matuszek +5 more
doaj +1 more source
Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
Frontiers in Endocrinology, 2022 There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner +5 more
doaj +1 more source
Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
Clinical Case Reports, 2022 A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald +4 more
doaj +1 more source
Survey on selenium clinical supplementation in autoimmune thyroid disease
European Thyroid Journal, 2023 Objective: Previous trials show that selenium could be a very useful tool in the control and treatment of autoimmune thyroid diseases. In this cross-sectional study, through a survey, we aim to evaluate Portuguese endocrinologists' perception and ...
Liliana Ribeiro Santos +5 more
doaj +1 more source
Acta Medica Indonesiana, 2023 We report a woman, 45th year old with Graves’ disease treated with anti-thyroid drug (thiamazole). She came to our clinic with severe and active Graves’ orbitopathy.
Laurentius Aswin Pramono
doaj +2 more sources
Case series of dermopathy in autoimmune thyroid disease [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"Graves' disease (GD) is an autoimmune disease that can affect other tissues in addition to the thyroid gland. The clinical manifestations are a result of the impact of TSH receptor antibodies.
Janić Tamara +8 more
doaj +1 more source
TNOA Journal of Ophthalmic Science and Research, 2017 Thyroid associated orbitopathy is used to describe the ocular manifestations of thyroid eye disease. The pathogenesis of the disorder is poorly understood. Considered to be an ophthalmic auto immune disease, it is usually associated with hyperthyroidism,
G Baskararajan, B Bhuvanasundari
doaj +1 more source